Uppsala, Sweden, December 10, 2025. Senzime AB (publ) today announced the launch of the latest series of innovative features for its next-generation TetraGraph ® system. The new EMGINE TM Sirius ...
UPPSALA, SE / ACCESS Newswire / October 8, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ) today announced the launch of EMGINETM, a proprietary software suite for its next-generation ...
UPPSALA, SE / ACCESS Newswire / May 26, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Lisbon, Portugal - Senzime AB (publ.) welcomes today's pre-announcement of the first pediatric guidelines of ...
An ED physician ordered a neuromuscular blocking agent to sedate a combative patient. However, a nurse administered the drug too soon, before the patient could be intubated. The patient arrested and ...
Muscle relaxants are a necessary part of anesthesia during certain major operations. Studies have, however, hinted at respiratory risks connected with these drugs. A major new study has confirmed the ...
Following laparoscopic cholecystectomy, the incidence of postoperative urinary retention is lower with sugammadex than with neostigmine used for reversal of neuromuscular blockade, a study shows.
(MENAFN- GlobeNewsWire - Nasdaq) The global neuromuscular transmission monitor market growth is driven by increasing ICU admissions, rising surgical volumes, and technological advancements in ...
UPPSALA, SE / ACCESS Newswire / December 10, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ) today announced the launch of the latest series of innovative features for its next-generation ...
Muscle relaxants are a necessary part of anesthesia during certain major operations. Studies have, however, hinted at respiratory risks connected with these drugs. POPULAR, a major prospective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results